" class="no-js "lang="en-US"> John Glasspool - Medtech Alert
Friday, May 23, 2025
John Glasspool

John Glasspool

About John Glasspool

Global pharmaceutical executive officer with a career defined by a passionate pursuit of solutions to fill unmet patient needs.

Experience leading franchises of $6+ billion in sales, with business in the U.S., UK, Europe, and developing markets.

Brings a broad appreciation and ability to build productive relationships with the multi-stakeholder system – including patients, medical professionals, payers, and policymakers – that impact success.

Extensive background leading product development from early stage to successful commercialization and lifecycle management.

Develops efficient commercial organizations with a well-conceived go-to-market model and mix of sales, key account managers, and medical affairs.

Builds and grows businesses through licensing, acquisitions, and partnerships.

Section 16 officer with ongoing interaction with the board and investment community.

Seamlessly bridges science and business as a holder of two patents in neuroscience and cardiovascular treatment.

Related Story

Anthos Therapeutics Appoints David McIntyre as Chief Financial Officer

January 6 2022

Anthos Therapeutics, a late-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today […]